GSA Capital Partners’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,825
| Closed | -$96K | – | 1672 |
|
|
2024
Q3 | $96K | Sell |
11,825
-30,294
| -72% | -$246K | 0.01% | 1493 |
|
|
2024
Q2 | $182K | Buy |
+42,119
| New | +$182K | 0.01% | 1472 |
|
|
2024
Q1 | – | Sell |
-24,721
| Closed | -$93K | – | 1668 |
|
|
2023
Q4 | $93K | Buy |
+24,721
| New | +$93K | 0.01% | 1400 |
|
|
2023
Q3 | – | Sell |
-38,311
| Closed | -$152K | – | 1551 |
|
|
2023
Q2 | $152K | Sell |
38,311
-42,330
| -52% | -$168K | 0.02% | 1334 |
|
|
2023
Q1 | $334K | Sell |
80,641
-55,915
| -41% | -$232K | 0.03% | 962 |
|
|
2022
Q4 | $576K | Buy |
136,556
+114,951
| +532% | +$485K | 0.07% | 517 |
|
|
2022
Q3 | $61K | Buy |
21,605
+3,056
| +16% | +$8.63K | 0.01% | 1407 |
|
|
2022
Q2 | $75K | Sell |
18,549
-29,473
| -61% | -$119K | 0.01% | 1255 |
|
|
2022
Q1 | $263K | Buy |
48,022
+13,469
| +39% | +$73.8K | 0.04% | 990 |
|
|
2021
Q4 | $157K | Buy |
34,553
+21,710
| +169% | +$98.6K | 0.02% | 1265 |
|
|
2021
Q3 | $60K | Sell |
12,843
-654
| -5% | -$3.06K | 0.01% | 1343 |
|
|
2021
Q2 | $93K | Sell |
13,497
-1,131
| -8% | -$7.79K | 0.01% | 1251 |
|
|
2021
Q1 | $146K | Buy |
+14,628
| New | +$146K | 0.02% | 963 |
|
|
2020
Q2 | – | Sell |
-21,428
| Closed | -$77K | – | 695 |
|
|
2020
Q1 | $77K | Buy |
+21,428
| New | +$77K | 0.02% | 928 |
|